Flibanserin powder is the first drug to be approved for hypoactive sexual desire disorder (HSDD) in premenopausal women by the FDA in August 2015.
Flibanserin-Pulver ass den éischten Drogen fir Hypoaktive sexuelle Verletzungssortiment (HSDD) an Premenopausal Fraen vun der FDA am August 2015.